Dominican Republic vs Lithuania: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Dominican Republic
0.1%
in 2024
Lithuania
0.1%
in 2024
Dominican Republic rank
112th
Lithuania rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Dominican Republic
- Lithuania
How they compare
Dominican Republic currently reports 0.1% against 0.1% in Lithuania, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Dominican Republic ahead.
Dominican Republic ranks 112th and Lithuania ranks 112th of 215 countries.
Dominican Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Dominican Republic | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.1% | 0.1% | Dominican Republic |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Dominican Republic or Lithuania?
- Dominican Republic, at 0.1% against 0.1% in Lithuania as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Dominican Republic and Lithuania?
- 0.0%, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Lithuania?
- 10 years are reported by both, from 2015 to 2024.
- How do Dominican Republic and Lithuania rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Dominican Republic ranks 112th and Lithuania ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.